Whereas patients with poor prognosis showed high expression levels of CT45A1, patients with lower expression of CT45A1 had prolonged survival, thereby suggesting that CT45A1 is a prognostic marker of osteosarcomas (Fig. 1E). This evidence concerns the gene CT45A1 and osteosarcoma.